Unique ID issued by UMIN | UMIN000040794 |
---|---|
Receipt number | R000046555 |
Scientific Title | The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903) |
Date of disclosure of the study information | 2020/07/01 |
Last modified on | 2023/07/11 17:26:23 |
The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903)
PALEM trial
The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903)
PALEM trial
Japan |
bone metastases
Medicine in general | Hematology and clinical oncology | Orthopedics |
Radiology |
Malignancy
NO
To verify the immediate efficacy and safety of palliative arterial embolization for painful bone metastases
Safety,Efficacy
1) pain relief at 72 hours after arterial embolization(TAE)
2) adverse events related to TAE 2 weeks after TAE
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Arterial embolization with a spherical embolic material is performed for painful bone metastases.
20 | years-old | <= |
100 | years-old | >= |
Male and Female
1)Diagnosed as painful bone metastases
2)Strongest pain site matches the bone metastasis site
3)No spinal cord compression in the bone metastasis site
4)The patient has pain described over 5 in Numerical Rating Scale.
5)Patient has received some form of analgesic medication for pain relief.
6)Radiation therapy (RT) has not been performed on the site of arterial embolization within 2 months.
7)The patuient has not been started new chemotherapy or
8)Originated cancer is not limited.
9)promising over 1 month alive after treatment
10)eGFR is over 30 ml/min/1.73m2
11)PT-INR is over 1.5 and Platelet count is over 50000/dl.
12)over 20 years old
13)Signed a consent form
1)Difficult to hold rest position
2)The patient could not describe pain by Numeric Rating Scale.
3)Preexisting disorders of being allergic to iodinated contrast material
4)Cannot stop anticoagulants and antithrombotic drugs.
5)Qualified ineligible patients being this clinical trial by responsible doctor
120
1st name | Yasunori |
Middle name | |
Last name | Arai |
National Cancer Center Hospital East
Department of Diagnostic Radiology
277-8577
6-5-1 Kashiwanoha, Kashiwa-shi, Chiba
04-7133-1111
yarai1976@gmail.com
1st name | Yasunori |
Middle name | |
Last name | Arai |
National Cancer Center Hospital East
Department of Diagnostic Radiology
277-8577
6-5-1 Kashiwanoha, Kashiwa-shi, Chiba
04-7133-1111
yarai1976@gmail.com
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Japan Agency for Medical Research and Development
Japanese Governmental office
Japan Supportive, Palliative and Psychosocial Oncology Group(J-SUPPORT)
National Cancer Center Hospital East
6-5-1 Kashiwanoha, Kashiwa-shi, Chiba
04-7133-1111
yarai1976@gmail.com
NO
愛知医科大学(愛知県)
愛知県がんセンター (愛知県)
岩手医科大学 放射線科 (岩手県)
がん研究会有明病院 (東京都)
国家公務員共済組合連合会斗南病院 (北海道)
国立がん研究センター中央病院 (東京都)
国立がん研究センター東病院 (千葉県)
静岡県立がんセンター (静岡県)
順天堂大学 (東京都)
聖マリアンナ医科大学 (神奈川県)
手稲渓仁会病院 (北海道)
奈良県立医科大学 (奈良県)
北海道大学病院 (北海道)
琉球大学医学部付属病院 (沖縄県)
・追加参加施設 2022/01 追加
大阪大学 (大阪府)
神戸大学 (兵庫県)
慶応大学病院 (東京都)
済生会福岡総合病院 (福岡県)
市立奈良病院 (奈良県)
函館五稜郭病院 (北海道)
兵庫医科大学病院 (兵庫県)
兵庫県立がんセンター (兵庫県)
福知山市民病院 (京都府)
北海道がんセンター (北海道)
2020 | Year | 07 | Month | 01 | Day |
Unpublished
Open public recruiting
2020 | Year | 06 | Month | 15 | Day |
2020 | Year | 11 | Month | 28 | Day |
2021 | Year | 03 | Month | 01 | Day |
2024 | Year | 12 | Month | 31 | Day |
2020 | Year | 06 | Month | 16 | Day |
2023 | Year | 07 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046555
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |